VA House · HB 433

Newborn screening; evaluation of disorders for inclusion, process for considering other disorders.

In plain English (AI summary)

This legislation updates the process by which Virginia decides which medical conditions are included in mandatory newborn screening panels. By streamlining the evaluation criteria and formalizing how the state considers emerging research for new disorders, the bill ensures that infants are tested for a broader, more evidence-based range of treatable conditions. For Arlington families, this means earlier identification of rare diseases, allowing for timely medical interventions that can significantly improve long-term health outcomes. By modernizing these protocols, the Commonwealth aims to keep pace with advancements in genetic testing technology, reducing the time it takes to adopt life-saving screening procedures across local hospitals. This proactive approach supports healthier starts for newborns by catching potentially debilitating health issues before symptoms even appear.

View original bill

Roll-call votes

Roll call
Mar 14, 2026 · VA House · pass
94 – 0 · 5 other
Full roll call
Adopt Conference Committee Report
Mar 13, 2026 · VA Senate · pass
39 – 0 · 1 other
Full roll call
Insist & Request
Mar 10, 2026 · VA Senate · pass
40 – 0
Full roll call
Roll call
Mar 6, 2026 · VA House · fail
3 – 94 · 2 other
Full roll call
Passage
Mar 4, 2026 · VA Senate · pass
40 – 0
Full roll call
Reported from Finance and Appropriations with substitute
Mar 3, 2026 · VA Senate · pass
14 – 0 · 1 other
Arlington delegation
Full roll call
Constitutional reading dispensed (on 2nd reading)
Mar 3, 2026 · VA Senate · pass
40 – 0
Full roll call
Reported from Education and Health
Feb 19, 2026 · VA Senate · pass
15 – 0
Arlington delegation
Full roll call
Roll call
Feb 2, 2026 · VA House · pass
99 – 0 · 1 other
Full roll call
Reported from Rules with substitute
Jan 27, 2026 · VA House · pass
18 – 0
Arlington delegation
Full roll call